E66.812 coverage policies: Medicare and commercial payers

23 active Medicare policies list E66.812, and 1 commercial payer policy lists it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.

Get free alerts for E66.812

Free account. Policy pages stay open to everyone.

Medicare policies listing E66.812

LCD · PALMETTO-JJ-L34576

Laparoscopic Sleeve Gastrectomy for Severe Obesity

JJ · Effective Oct 1, 2015

LCD · PALMETTO-JM-L34576

Laparoscopic Sleeve Gastrectomy for Severe Obesity

JM · Effective Oct 1, 2015

LCD · CGS-J15-L40198

MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

J15

LCD · WPS-J5-L40271

MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

LCD · WPS-J8-L40271

MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

LCD · CGS-J15-L40199

MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

J15 · Effective Aug 10, 2026

LCD · NORIDIAN-JE-L40197

MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

JE · Effective Aug 10, 2026

LCD · NORIDIAN-JF-L40197

MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

Commercial payer policies listing E66.812

1 policy from 1 payer

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Anthem

Anthem policies listing E66.812, with the code’s status in each
Policy	Effective	Status of E66.812
Bariatric Surgery and Other Treatments for Clinically Severe ObesityClinical Guideline · ANTHEM-CG-SURG-83	Oct 1, 2026	Covered

E66.812 coverage policies: Medicare and commercial payers

Medicare policies listing E66.812

Laparoscopic Sleeve Gastrectomy for Severe Obesity

Laparoscopic Sleeve Gastrectomy for Severe Obesity

MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

Commercial payer policies listing E66.812

Anthem

E66.812 coverage policies: Medicare and commercial payers

Medicare policies listing E66.812

Laparoscopic Sleeve Gastrectomy for Severe Obesity

Laparoscopic Sleeve Gastrectomy for Severe Obesity

MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

Commercial payer policies listing E66.812

Anthem

MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

Outpatient Psychiatry and Psychology Services

Surgical Management of Morbid Obesity

Transesophageal Echocardiogram

Vitamin D Assay Testing

Vitamin D Assay Testing

Billing and Coding: Bariatric Surgery for Treatment of Co-Morbidities Conditions Related to Morbid Obesity

Billing and Coding: Laparoscopic Sleeve Gastrectomy for Severe Obesity

Billing and Coding: Outpatient Psychiatry and Psychology Services

Billing and Coding: Surgical Management of Morbid Obesity

Billing and Coding: Transesophageal Echocardiogram

Billing and Coding: Vitamin D Assay Testing